Praxair (PX) Price Target Raised to $180.00 at JPMorgan Chase & Co.

Praxair (NYSE:PX) had its price target lifted by investment analysts at JPMorgan Chase & Co. from $179.00 to $180.00 in a report issued on Friday. The firm currently has an “overweight” rating on the basic materials company’s stock. JPMorgan Chase & Co.’s price target suggests a potential upside of 12.63% from the stock’s current price.

A number of other research firms also recently weighed in on PX. Citigroup decreased their target price on shares of Praxair from $188.00 to $163.00 and set a “buy” rating for the company in a research report on Tuesday, April 10th. ValuEngine downgraded shares of Praxair from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. TheStreet raised shares of Praxair from a “c+” rating to an “a-” rating in a research report on Thursday, April 26th. Zacks Investment Research downgraded shares of Praxair from a “buy” rating to a “hold” rating in a research report on Tuesday, March 27th. Finally, BMO Capital Markets started coverage on shares of Praxair in a research report on Tuesday, March 27th. They set a “market perform” rating and a $159.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $174.50.

Shares of Praxair stock traded down $1.73 on Friday, hitting $159.82. The stock had a trading volume of 579,488 shares, compared to its average volume of 1,210,862. Praxair has a twelve month low of $127.36 and a twelve month high of $166.95. The company has a debt-to-equity ratio of 1.07, a current ratio of 0.94 and a quick ratio of 0.77. The company has a market capitalization of $46.08 billion, a P/E ratio of 27.32, a P/E/G ratio of 2.06 and a beta of 1.08.



Praxair (NYSE:PX) last released its quarterly earnings data on Thursday, April 26th. The basic materials company reported $1.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.56 by $0.09. Praxair had a return on equity of 26.91% and a net margin of 11.27%. The company had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.93 billion. equities analysts anticipate that Praxair will post 6.76 EPS for the current year.

Several institutional investors have recently bought and sold shares of PX. Private Capital Group LLC boosted its holdings in shares of Praxair by 394.0% during the 1st quarter. Private Capital Group LLC now owns 741 shares of the basic materials company’s stock worth $107,000 after buying an additional 591 shares in the last quarter. Institutional & Family Asset Management LLC bought a new position in shares of Praxair during the 1st quarter worth approximately $137,000. M&R Capital Management Inc. boosted its holdings in shares of Praxair by 366.5% during the 4th quarter. M&R Capital Management Inc. now owns 933 shares of the basic materials company’s stock worth $144,000 after buying an additional 733 shares in the last quarter. Signaturefd LLC bought a new position in shares of Praxair during the 1st quarter worth approximately $147,000. Finally, Cornerstone Advisors Inc. boosted its holdings in shares of Praxair by 123.1% during the 1st quarter. Cornerstone Advisors Inc. now owns 1,042 shares of the basic materials company’s stock worth $150,000 after buying an additional 575 shares in the last quarter. Hedge funds and other institutional investors own 85.70% of the company’s stock.

About Praxair

Praxair, Inc produces and distributes industrial gases. It operates through five segments: North America, Europe, South America, Asia, and Surface Technologies. The company offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Analyst Recommendations for Praxair (NYSE:PX)

Receive News & Ratings for Praxair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Praxair and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply